The Quality Assurance and Regulatory Affairs team at BiomeBank ensures that all microbial therapies meet stringent quality standards and regulatory requirements. They oversee the entire production process, from development to manufacturing, to guarantee compliance with global and regional regulations, thereby ensuring patient safety and efficacy of the treatments. This team is crucial for securing necessary approvals and maintaining the highest quality in drug products aimed at treating conditions such as Clostridoides difficile, Ulcerative Colitis, and Crohn's Disease.
View all